- Home
- GTBP vs IDAI Comparison
GTBP vs IDAI Comparison
Compare GTBP & IDAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GTBP
- IDAI
- Stock Information
- Founded
- GTBP 1965
- IDAI 2016
- Country
- GTBP United States
- IDAI United States
- Employees
- GTBP N/A
- IDAI N/A
- Industry
- GTBP Biotechnology: Pharmaceutical Preparations
- IDAI Computer Software: Prepackaged Software
- Sector
- GTBP Health Care
- IDAI Technology
- Exchange
- GTBP Nasdaq
- IDAI Nasdaq
- Market Cap
- GTBP 5.5M
- IDAI 4.6M
- IPO Year
- GTBP N/A
- IDAI N/A
- Fundamental
- Price
- GTBP $3.48
- IDAI $2.66
- Analyst Decision
- GTBP Strong Buy
- IDAI
- Analyst Count
- GTBP 1
- IDAI 0
- Target Price
- GTBP $11.00
- IDAI N/A
- AVG Volume (30 Days)
- GTBP 75.0K
- IDAI 37.6K
- Earning Date
- GTBP 08-13-2025
- IDAI 08-12-2025
- Dividend Yield
- GTBP N/A
- IDAI N/A
- EPS Growth
- GTBP N/A
- IDAI N/A
- EPS
- GTBP N/A
- IDAI N/A
- Revenue
- GTBP N/A
- IDAI $3,054,143.00
- Revenue This Year
- GTBP N/A
- IDAI $65.46
- Revenue Next Year
- GTBP N/A
- IDAI $12.00
- P/E Ratio
- GTBP N/A
- IDAI N/A
- Revenue Growth
- GTBP N/A
- IDAI N/A
- 52 Week Low
- GTBP $1.72
- IDAI $1.43
- 52 Week High
- GTBP $4.10
- IDAI $18.75
- Technical
- Relative Strength Index (RSI)
- GTBP 76.91
- IDAI 66.87
- Support Level
- GTBP $2.75
- IDAI $1.90
- Resistance Level
- GTBP $3.28
- IDAI $2.62
- Average True Range (ATR)
- GTBP 0.26
- IDAI 0.21
- MACD
- GTBP 0.07
- IDAI 0.05
- Stochastic Oscillator
- GTBP 96.72
- IDAI 96.34
About GTBP GT Biopharma Inc.
GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.
About IDAI T Stamp Inc.
T Stamp Inc develops and markets identity authentication software solutions for enterprise partners and peer-to-peer markets. The company is engaged in developing proprietary artificial intelligence-powered solutions; researching and leveraging biometric science, cryptography, and data mining to deliver insightful identity & trust predictions while identifying and defending against fraudulent identity attacks, protecting sensitive user information, and extending the reach of digital services through accessibility. The artificial intelligence-powered solutions segment generates revenue principally from software licenses, professional services, and recurring Software-as-a-Service ("SaaS") revenue.